

Publisher: Bentham Science Publishers
E-ISSN: 1873-4316|12|3|352-361
ISSN: 1389-2010
Source: Current Pharmaceutical Biotechnology, Vol.12, Iss.3, 2011-03, pp. : 352-361
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content








Pharmacotherapy for diabetic retinopathy
By Schwartz Stephen G Flynn Harry W Scott Ingrid U
Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 7, 2009-05 ,pp. :


Emerging drugs for diabetic retinopathy
Expert Opinion on Emerging Drugs, Vol. 13, Iss. 4, 2008-12 ,pp. :